Compile Data Set for Download or QSAR
maximum 50k data
Found 31 with Last Name = 'zeitlmann' and Initial = 'l'
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120943(US8716296, 89)
Affinity DataIC50:  0.00500nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120941(US8716296, 82)
Affinity DataIC50:  0.0150nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120934(US8716296, 2)
Affinity DataIC50:  0.0180nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120936(US8716296, 5 | US8716296, 6)
Affinity DataIC50:  0.0190nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120942(US8716296, 83)
Affinity DataIC50:  0.0290nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120935(US8716296, 3)
Affinity DataIC50:  0.0390nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120939(US8716296, 52)
Affinity DataIC50:  0.116nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120936(US8716296, 5 | US8716296, 6)
Affinity DataIC50:  0.173nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120940(US8716296, 53)
Affinity DataIC50:  1.08nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120938(US8716296, 51)
Affinity DataIC50:  1.25nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM120933(US8716296, 1)
Affinity DataIC50:  10nMpH: 7.5Assay Description:All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50 μl reaction volume. The reaction mixt...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Ingenium Pharmaceuticals

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50:  10nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  94nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 alpha(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50:  99nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 alpha(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  160nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  168nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 3(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  219nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50:  857nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  903nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50:  913nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 5(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50:  1.08E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 5(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50:  1.34E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 3(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50:  1.45E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50:  1.88E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInterleukin-1 receptor-associated kinase 1(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 7(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 7(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 6(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCyclin-dependent kinase 6(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetInterleukin-1 receptor-associated kinase 1(Homo sapiens (Human))
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: >5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails US Patent